These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2738 related articles for article (PubMed ID: 30908927)

  • 41. Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS).
    Torén K; Olin AC; Lindberg A; Vikgren J; Schiöler L; Brandberg J; Johnsson Å; Engström G; Persson HL; Sköld M; Hedner J; Lindberg E; Malinovschi A; Piitulainen E; Wollmer P; Rosengren A; Janson C; Blomberg A; Bergström G
    Int J Chron Obstruct Pulmon Dis; 2016; 11():927-33. PubMed ID: 27194908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of gastroesophageal reflux on longitudinal lung function and quantitative computed tomography in the COPDGene cohort.
    Baldomero AK; Wendt CH; Petersen A; Gaeckle NT; Han MK; Kunisaki KM;
    Respir Res; 2020 Aug; 21(1):203. PubMed ID: 32746820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics and self-rated health of overlap syndrome.
    Chung JW; Kong KA; Lee JH; Lee SJ; Ryu YJ; Chang JH
    Int J Chron Obstruct Pulmon Dis; 2014; 9():795-804. PubMed ID: 25092973
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial.
    Hanania NA; Sharafkhaneh A; Celli B; Decramer M; Lystig T; Kesten S; Tashkin D
    Respir Res; 2011 Jan; 12(1):6. PubMed ID: 21219660
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Significant Spirometric Transitions and Preserved Ratio Impaired Spirometry Among Ever Smokers.
    Wan ES; Hokanson JE; Regan EA; Young KA; Make BJ; DeMeo DL; Mason SE; San Jose Estepar R; Crapo JD; Silverman EK
    Chest; 2022 Mar; 161(3):651-661. PubMed ID: 34592319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
    Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overall Response to Anti-IL-5/Anti-IL5-Rα Treatment in Severe Asthma Does Not Depend on Initial Bronchodilator Responsiveness.
    Mümmler C; Suhling H; Walter J; Kneidinger N; Buhl R; Kayser MZ; Drick N; Behr J; Welte T; Korn S; Milger K
    J Allergy Clin Immunol Pract; 2022 Dec; 10(12):3174-3183. PubMed ID: 35870725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. People with older age and lower FEV1%pred tend to have a smaller FVC than VC in pre-bronchodilator spirometry.
    Wang W; Ma D; Li T; Ying Y; Xiao W
    Respir Physiol Neurobiol; 2014 Apr; 194():1-5. PubMed ID: 24448311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of active and passive smoking as risk factors for asthma and COPD in women presenting to primary care in Syria: first report by the WHO-GARD survey group.
    Mohammad Y; Shaaban R; Al-Zahab BA; Khaltaev N; Bousquet J; Dubaybo B
    Int J Chron Obstruct Pulmon Dis; 2013; 8():473-82. PubMed ID: 24124359
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010.
    Tilert T; Dillon C; Paulose-Ram R; Hnizdo E; Doney B
    Respir Res; 2013 Oct; 14(1):103. PubMed ID: 24107140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved criterion for assessing lung function reversibility.
    Ward H; Cooper BG; Miller MR
    Chest; 2015 Oct; 148(4):877-886. PubMed ID: 25879725
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of the new European respiratory (ERS)/American Thoracic Society (ATS) pulmonary function test interpretation guidelines 2021 on the interpretation of bronchodilator responsiveness in subjects with airway obstruction.
    Chaiwong W; Deesomchok A; Pothirat C; Duangjit P; Liwsrisakun C
    Respir Med; 2023 Dec; 220():107460. PubMed ID: 37949150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study.
    Tan WC; Vollmer WM; Lamprecht B; Mannino DM; Jithoo A; Nizankowska-Mogilnicka E; Mejza F; Gislason T; Burney PG; Buist AS;
    Thorax; 2012 Aug; 67(8):718-26. PubMed ID: 22544896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased Accuracy After Adjustment of Spirometry Threshold for Diagnosing COPD Based on Pre-Bronchodilator FEV
    Kronborg T; Hangaard S; Cichosz SL; Hejlesen O
    Respir Care; 2019 Jan; 64(1):85-90. PubMed ID: 30578360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting inadequate spirometry technique and the use of FEV1/FEV3 as an alternative to FEV1/FVC for patients with mild cognitive impairment.
    Allen S; Yeung P; Janczewski M; Siddique N
    Clin Respir J; 2008 Oct; 2(4):208-13. PubMed ID: 20298336
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease.
    Vaz Fragoso CA; Concato J; McAvay G; Van Ness PH; Rochester CL; Yaggi HK; Gill TM
    Am J Respir Crit Care Med; 2010 Mar; 181(5):446-51. PubMed ID: 20019341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.
    Pisi R; Aiello M; Zanini A; Tzani P; Paleari D; Marangio E; Spanevello A; Nicolini G; Chetta A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1191-7. PubMed ID: 26150710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bronchodilator Reversibility in the GAN Severe Asthma Cohort.
    Milger K; Skowasch D; Hamelmann E; Mümmler C; Idzko M; Gappa M; Jandl M; Körner-Rettberg C; Ehmann R; Schmidt O; Taube C; Holtdirk A; Timmermann H; Buhl R; Korn S
    J Investig Allergol Clin Immunol; 2023 Dec; 33(6):446-456. PubMed ID: 36000830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessing bronchodilator response by changes in per cent predicted forced expiratory volume in one second.
    Ioachimescu OC; Ramos JA; Hoffman M; McCarthy K; Stoller JK
    J Investig Med; 2021 Jun; 69(5):1027-1034. PubMed ID: 33574095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 137.